CHAMPION FOR CHANGE: Using BioAssemblyBot, Dr. Doris Taylor, is developing a groundbreaking way to engineer personalized hearts using a patient's own stem cells. https://cnn.it/3BzZFff
Advanced Solutions Life Sciences
生物技术研究
Louisville,KY 1,670 位关注者
Advanced Solutions designs and manufactures robotic and vascular platforms for building human tissues.
关于我们
Advanced Solutions Life Sciences (ASLS) is dedicated to the discovery, design, and development of integrated software and hardware solutions for the fields of science that involve living organisms, molecular biology, and biotechnology. ASLS offers a full service business model including its patent pending BioAssemblyBot? Technology Platform, BioBot? Basic platform, TSIM? Software, VIPM?, Professional Services and Supplies.
- 网站
-
https://advancedsolutions.com
Advanced Solutions Life Sciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Louisville,KY
- 类型
- 私人持股
- 创立
- 2013
- 领域
- BioTechnology、Robotics、3D Bioprinting、3D Software和Biofabrication
地点
-
主要
1901 Nelson Miller Parkway
US,KY,Louisville,40223
Advanced Solutions Life Sciences员工
动态
-
Transforming Tissue Engineering: Angiomics? Microvessels with BAB400 Advanced Solutions Life Sciences is setting new standards for tissue vascularization with Angiomics? Microvessels. Leveraging human adipose-derived microvessels, this vascularization platform enables the development of more lifelike 3D tissue models and organoid assays, promoting stable vascularization and enhancing parenchyma functionality. ?? Whole Microvessel Innovation: Angiomics microvessels retain the full complement of vascular cells and are harvested using an exclusive process, making it possible to replicate native angiogenesis and integrate perfusable microcirculation within tissue models. ?? Enhanced Research Outcomes: With over 50 peer-reviewed publications since 1996, Angiomics has proven its value across various research applications, including angiogenesis, microvascular biology, and disease modeling. ?? Streamlined with BAB400 BioAssemblyBot?: The BAB400 provides precision bioassembly, allowing seamless integration of Angiomics microvessels into diverse tissue environments, supporting research efforts in both in vitro and in vivo applications. Key Benefits: ? Recapitulates native angiogenesis ? Full suite of microvascular cells ? Phenotypically dynamic within 3D tissue environments Dive into this cutting-edge approach to vascularization and explore how Angiomics? and the BAB400 can elevate your research. https://lnkd.in/gmx7A4Bn #TissueEngineering #BioAssembly #AdvancedSolutions #Angiomics #3DTissueModels #LifeSciences #ResearchInnovation
-
-
BioApp Development with our simple Drag-and-Drop Interface! Say goodbye to complex coding and hello to effortless BioApp creation! With the BioApps Market, browse and customize ready-made BioApps. ?? Intuitive Interface: Accessible for all skill levels—no coding experience required. ?? Versatile Library: Create new BioApps or repurpose existing ones from our extensive collection. ?? Accelerate Innovation: Speed up your development process and bring your ideas to life faster than ever. What BioApp would you create with our drag-and-drop tool? Share your ideas below! ?? Ready to innovate? Visit us at https://lnkd.in/gCa_c-hA Check out the BioApp Market at https://lnkd.in/gH9d4QzE #BioAppsMarket #Bioinformatics #BiotechInnovation #DragAndDrop
-
More than a Bioprinter, Much More. BioAssemblyBot (BAB) is transforming the landscape of life sciences. ?? Integration at Its Best: BAB seamlessly fits into modern biology and drug discovery labs, working hand-in-hand with equipment like confocal microscopes—including Cytiva’s IN Cell Analyzer and Molecular Devices’ ImageXpress. ?? Beyond Bioprinting: Unlike traditional bioprinters, BAB doesn’t just print—she manipulates tissue assays over time, nurturing and analyzing biology throughout your entire workflow. ??? Adaptive and Intelligent: Equipped with machine vision and AI, BAB continuously improves with each task, automating calibration and correcting errors to keep your biology thriving. ?? Versatile ‘Hands’: With the ability to swap out different BioAssemblyBot Hands during a run, you can control temperature, pressure, UV exposure, and more—all tailored to your project’s needs. We’re excited about the possibilities BAB brings to the future of medicine, drug discovery, and biofabrication. https://lnkd.in/gW2Tez52 #BioAssemblyBot #Innovation #Bioprinting #LifeSciences #Integration #AIinHealthcare
-
Our latest insights on how the BioAssemblyBot 400 is revolutionizing cancer therapy! ??? Our new blog post delves into how this advanced biofabrication robot automates the precise creation of AS1411-conjugated gold nanoparticles. These nanoparticles are game-changers in targeting cancer cells more effectively, potentially leading to better patient outcomes. Discover how precision automation is accelerating the development of nanoparticle-based treatments and paving the way for innovative cancer therapies. Read the full article here: https://lnkd.in/g4jPH88M #CancerResearch #Nanotechnology #BioAssemblyBot #HealthcareInnovation
-
-
The versatility of the BioAssemblyBot? Platform is unparalleled! This powerful platform brings automation to your lab; check out these four key applications: 1?? Matrigel?-Organoid Dome Printing – Precision handling for high-quality organoid cultures. 2?? 8-Channel Pipetting – High-throughput liquid handling to streamline your workflow. 3?? Automated Workflow Operations – Save time and improve consistency with fully automated workflows. 4?? Single-Cell Dispensing – Achieve unprecedented accuracy in isolating and dispensing individual cells. Ready to revolutionize your research? All of this can be done on ONE platform. #Automation #BioAssemblyBot #LabAutomation #Organoids #Bioprinting #Innovation
-
-
? Highlighting the innovative 3D Liver BioApp from Advanced Solutions! This tool continues to revolutionize the way we approach disease modeling, drug toxicity assessment, and liver cancer research. ? The 3D Liver BioApp allows for the automated fabrication of highly advanced, customizable 3D human vascularized liver tissue models. By integrating primary hepatocytes, non-parenchymal cells, and human adipose-derived microvessel fragments, the BioApp creates dense, functional liver tissue that closely mimics the in vivo environment. ? Key Highlights: ? - Advanced tissue modeling with unparalleled fidelity to native liver environments. - Streamlined workflows for complex 3D vascularized tissue environments. - Flexibility in tissue size, composition, and configuration, tailored to specific research needs. Compatible with BioAssembly? automation and high-content imaging, enabling seamless integration into existing research frameworks. As we continue to push the boundaries of liver biology and therapeutic discoveries, tools like the 3D Liver BioApp are essential for driving innovation forward. https://lnkd.in/g8Y7sz_j ? #BioTech #3DLiver #AdvancedSolutions #Innovation #LiverResearch #Biotechnology #DrugDevelopment
-
-
?? Revolutionizing Tumor Spheroid Workflows: Robot vs. Human ???? In the rapidly advancing field of drug discovery and screening, the precision and efficiency of spheroid culture techniques are crucial. Our recent update showcases how automation with the BioAssembly? Platform is setting new standards in tumor spheroid workflows. ? Key Insights: Automated Precision: Our BioAssemblyBot? 400, integrated with BioStorageBot? and ImageXpress? Confocal HT.ai, automates the entire process of spheroid fabrication, culture, and imaging. This ensures greater consistency and reduces the risk of human error. Improved Efficiency: Automation not only speeds up the workflow but also enhances spheroid morphology. For instance, automated spheroid formation achieved 81.25% successful domes compared to 72.0% manually. Consistency Matters: Daily culture medium exchanges and imaging via automation resulted in fewer spheroid fragments and better size consistency compared to manual methods. ?? Results: Size & Quality: Automated spheroids maintained a larger average diameter and consistent growth compared to manually handled ones. Automated workflows took 40 min 26 sec compared to 41 min 24 sec for manual processes, showcasing time efficiency without compromising quality. ?? Looking Ahead: This innovation opens doors to more complex assays and higher throughput operations. The BioAssembly? Platform’s flexibility and precision are paving the way for advanced research and drug development. ?? Dive into the full details and see how automation is transforming spheroid cultures in our latest blog update! https://lnkd.in/gmhs8A3B #Biotech #Automation #DrugDiscovery #CellCulture #BioAssembly #ResearchInnovation
Advanced Solutions | 3D Bioprinting & Vascularization Experts
advancedsolutions.com
-
A big thank you to everyone who visited our booth and attended our presentations at the TERMIS World Congress. Visit our website or contact us to learn more about our latest innovations in regenerative medicine. Let’s continue the conversation! #TERMIS2024 #ThankYou #AdvancedSolutions
-
-
Enjoying time with our Advanced Solutions team at TERMIS 2024! From presenting our work to engaging with attendees, it’s happening here. #TERMIS2024 #BehindTheScenes #TeamWork
-